Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Profile: Abe Abuchowski

Nature Biotechnology volume 24, page 1050 (2006)Cite this article

As CEO of one of the first companies to make protein delivery into a profitable business, Abe Abuchowski knows what it takes to bring a new technology to market. Although his technology—PEGylation—is now considered an industry gold standard, its three-decade development history illustrates the often rocky path to commercial success for platforms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. New York

    Alla Katsnelson

Authors
  1. Alla Katsnelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Katsnelson, A. Profile: Abe Abuchowski. Nat Biotechnol 24, 1050 (2006). https://doi.org/10.1038/nbt0906-1050

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0906-1050

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing